Israel’s DreaMed Diabetes said on Monday the U.S. Food and Drug Administration has approved for marketing its Advisor Pro software to help manage diabetes treatment.
Read more on Reuters here.
[DreaMed in Reuters] Israel’s DreaMed gets FDA ok for diabetes management software
![[DreaMed in Reuters] Israel’s DreaMed gets FDA ok for diabetes management software](https://blog.ourcrowd.com/wp-content/uploads/2017/11/reuters-NEW.jpg)
![[Intuition Robotics in The Jerusalem Post] Israeli ‘loneliness’ robot company raises $36 million](https://blog.ourcrowd.com/wp-content/uploads/2017/10/Jerusalem-post.jpg)
![[Portfolio Companies in Aish] Israel’s COVID-19 Innovation](https://blog.ourcrowd.com/wp-content/uploads/2020/06/aish.jpg)
![[Klook in South China Morning Post] Hong Kong travel start-up Klook raises US$60m in latest funding round to expand globally](https://blog.ourcrowd.com/wp-content/uploads/2018/08/SCMP_color.png)
![[Zebra in CNBC] Google strikes deal with start-up to offer AI medical image scanning via its cloud](https://blog.ourcrowd.com/wp-content/uploads/2017/09/CNBC-1.jpg)
